For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track how the tumor progresses. The achievement, say researchers who led the research, represents a critical advance in the effort to understand the origin and drivers of this puzzling cancer — the most common in men.